Chemiluminescence depth report in the gold segment of the in vitro diagnostic industry
This report details the overall situation of the chemiluminescence industry, analyzes the competitive landscape, and points out that import substitution is the direction of industry development. Compare domestic and imported products and explain the pain points of the industry in import substitution. In the process of writing, we investigated a number of hospitals, testing terminals and dealers, and analyzed the first-hand data to draw more practical conclusions.
1. Chemiluminescence is a golden segment of the IVD industry.
1.1 In vitro diagnostic potential is large, luminescence growth rate of up to 30%
In vitro diagnosis is mainly divided into biochemical diagnosis, immunodiagnosis, molecular diagnosis, microbial diagnosis, coagulation diagnosis, tissue diagnosis, urine diagnosis, hematology and flow cytometry. Among them, biochemical diagnosis, immunodiagnosis and molecular diagnosis are currently domestic. The mainstream IVD approach to medical institutions.
Compared with the European and American markets, China's in vitro diagnostic industry started late, but its development is rapid. In 2015, China's IVD market reached 45 billion. It is expected that the market capacity in 2017 is expected to increase to 60 billion.
In terms of product structure, China's in vitro diagnostic industry generally presents an “olive-type†structure: the low-end market is a widely used inspection technology in the early stage, with small development space and slow growth rate, and is undergoing methodological update and iteration; the mid-end market is near In the past few years, domestic R&D capability has been rapidly improved, channel advantages are obvious, domestic products are in a stage of rapid development; high-end market due to high technical barriers, large differences at home and abroad, mainly for foreign products, domestic products are currently in the incubation period of development, the future will usher in growth .
In terms of market composition, the in vitro diagnostic industry mainly consists of biochemical diagnosis, immunodiagnosis and molecular diagnosis. The biochemical market has experienced a process from closed to open. At present, the market is full of competition and the degree of homogenization of products is high, and import substitution has been basically achieved. In the molecular diagnostic market, technical barriers have not yet broken through. In the immunodiagnosis part, chemiluminescence has been developed and developed, and it is becoming the mainstream diagnostic tool. Chemiluminescence is the mainstream of immunotechnology, and currently accounts for nearly two-fifths of the market. The stock market is undergoing technological change. With the increase of health awareness, medical investment is increasing, and incremental demand is also growing. There are about 20 billion market capacity, and it is expected to maintain a growth rate of 25%-30% within 3 to 5 years. .
Erythritol For Juice,Organic Erythritol For Juice,Liquid Erythritol,Puresweet Erythritol
Ningxia Eppen Biotec CO.,LTD , https://www.nxeppen.com